Harmony Biosciences (HRMY) Tops Q4 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Harmony Biosciences Holdings Inc. (HRMY) PT Raised to $34 at Raymond James
February 22, 2024 12:00 PM ESTRaymond James analyst Danielle Brill raised the price target on Harmony Biosciences Holdings Inc. (NASDAQ: HRMY) to $34.00 (from $27.00) while maintaining a Outperform rating.
The analyst comments "Last month, HRMY preannounced 4Q Wakix sales and provided preliminary FY24 guidance that came in-line w/... More



